Tech Company Financing Transactions
TargeGen Funding Round
TargeGen, based in San Diego, scored $30 million from Chicago Growth Partners, Enterprise Partners Venture Capital and Forward Ventures.
Transaction Overview
Company Name
Announced On
8/31/2005
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series C
Investors
Proceeds Purpose
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
9380 Judicial Drive
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
TargeGen, Inc. is a privately held, vascular biology-focused, biopharmaceutical company based in San Diego, CA. TargeGen is developing novel small molecule therapeutics to treat cancer and ischemic diseases (heart attack, stroke) by targeting certain biochemical processes associated with disease related changes in vascular permeability and vascular proliferation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Ulrich
Chief Financial Officer
Wood Erwin
Vice President
Jolene Shorr
VP - Regulatory Affairs
David McClure
Browse more venture capital transactions:
Prev: 8/31/2005: Allworx venture capital transaction
Next: 8/31/2005: StrataVia venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs